Skip to main content

Dodge & Cox

Position in GILD — Gilead Sciences, Inc.

CIK 200217 San Francisco, CA

Position in GILD

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$3,379,837,619
+$153,799,479 QoQ
Shares Held
24,250,826
-7.7% QoQ
Ownership
1.95%
of shares outstanding
% of Portfolio
1.95%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 96.1665223279405.ToString("F0")% Shared 0.ToString("F0")% None 3.8334776720595003.ToString("F0")%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Mar 31, 2026

Dodge & Cox holds $10,175,049,986 across 13 Drug Manufacturers - General names. GILD ranks #1 (33.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 GILD
Gilead Sciences, Inc.
This page
24,250,826 $3,379,837,619

All Filings in GILD

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $3,379,837,619 24,250,826
2025-12-31 $3,226,038,140 26,283,511
2025-09-30 $3,344,777,541 30,133,131
2025-06-30 $3,416,827,360 30,818,322
2025-03-31 $3,663,451,331 32,694,791
2024-12-31 $3,043,380,619 32,947,717
2024-09-30 $2,770,554,590 33,045,737
2024-06-30 $2,272,523,541 33,122,337
2024-03-31 $2,429,518,422 33,167,487
2023-12-31 $2,697,229,813 33,295,023
2023-09-30 $2,513,018,325 33,533,738
2023-06-30 $2,618,819,871 33,979,757
2023-03-31 $2,879,205,193 34,701,762
2022-12-31 $3,080,740,299 35,885,152
2022-09-30 $2,243,619,155 36,369,252
2022-06-30 $2,284,907,214 36,966,627
2022-03-31 $2,201,233,153 37,026,630
2021-12-31 $2,699,260,557 37,174,777
2021-09-30 $2,603,078,436 37,266,692
2021-06-30 $1,994,312,577 28,961,844
2021-03-31 $1,193,208,754 18,462,150
2020-12-31 $996,705,554 17,107,888
2020-09-30 $796,690,231 12,607,853
2020-06-30 $968,867,873 12,592,512
2020-03-31 $1,129,695,444 15,110,961